A candidate gene approach to searching for low-penetrance breast and prostate cancer genes

[1]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[2]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[3]  E. Giovannucci,et al.  The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  Douglas F. Easton,et al.  Association studies for finding cancer-susceptibility genetic variants , 2004, Nature Reviews Cancer.

[5]  D. Altshuler,et al.  The multiethnic cohort study: exploring genes, lifestyle and cancer risk , 2004, Nature Reviews Cancer.

[6]  S. Hankinson,et al.  Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.

[7]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[8]  Nathaniel Rothman,et al.  Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .

[9]  Kenneth C Johnson,et al.  Passive and active smoking and breast cancer risk in Canada, 1994–97 , 2000, Cancer Causes & Control.

[10]  R. Kaaks.  Nutrition, hormones, and breast cancer: Is insulin the missing link? , 1996, Cancer Causes & Control.

[11]  Brian Staats,et al.  SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes , 2004, Nucleic Acids Res..

[12]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.

[13]  D. Altshuler,et al.  Human Genome Sequence Variation and the Search for Genes Influencing Stroke , 2003, Stroke.

[14]  E. Cavalieri,et al.  Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  A. Hirvonen,et al.  Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. , 2003, Mutation research.

[16]  Christopher A. Haiman,et al.  Choosing Haplotype-Tagging SNPS Based on Unphased Genotype Data Using a Preliminary Sample of Unrelated Subjects with an Example from the Multiethnic Cohort Study , 2003, Human Heredity.

[17]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[18]  E. Rimm,et al.  Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  M. Thun,et al.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort , 2002, Cancer.

[20]  M. Stampfer,et al.  Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer , 2002 .

[21]  J. Buring,et al.  Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study. , 2002, Controlled clinical trials.

[22]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[23]  Thomas E Rohan,et al.  Cigarette smoking and the risk of breast cancer in women: a review of the literature. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  Pardis C Sabeti,et al.  Detecting recent positive selection in the human genome from haplotype structure , 2002, Nature.

[25]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[26]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[27]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[28]  M. Thun,et al.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort , 2002, Cancer.

[29]  H. Olsson,et al.  A population-based cohort study of HRT use and breast cancer in southern Sweden , 2001, British Journal of Cancer.

[30]  G. Colditz,et al.  A polymorphism in CYP17 and endometrial cancer risk. , 2001, Cancer research.

[31]  T. Fears,et al.  Insulin-like growth factors and prostate cancer: a population-based case-control study in China. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  D. Grabrick,et al.  Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  Pui-Yan Kwok,et al.  Single-nucleotide polymorphisms in the public domain: how useful are they? , 2001, Nature Genetics.

[34]  S. Narod,et al.  Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[36]  M. Pike,et al.  Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype. , 2001, Cancer research.

[37]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[38]  J. Gohagan,et al.  Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. , 2000, Controlled clinical trials.

[39]  R. Shore,et al.  Serum insulin‐like growth factor‐I and breast cancer , 2000, International journal of cancer.

[40]  T. Rohan,et al.  Role of the insulin-like growth factor family in cancer development and progression. , 2000, Journal of the National Cancer Institute.

[41]  J R Marshall,et al.  Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. , 2000, American journal of epidemiology.

[42]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[43]  J. Yager,et al.  Tissue-specific synthesis and oxidative metabolism of estrogens. , 2000, Journal of the National Cancer Institute. Monographs.

[44]  M. Pike,et al.  Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. , 2000, Journal of the National Cancer Institute.

[45]  C. Ambrosone,et al.  Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. , 2000, Journal of the National Cancer Institute. Monographs.

[46]  I. McCutcheon,et al.  The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.

[47]  T. Hansen,et al.  Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. , 2000, The Journal of clinical endocrinology and metabolism.

[48]  van Houten Me,et al.  Differences in reproductive endocrinology between Asian men and Caucasian men--a literature review. , 2000 .

[49]  A. López-Bermejo,et al.  Genetic Defects of the Growth Hormone–Insulin-like Growth Factor Axis , 2000, Trends in Endocrinology & Metabolism.

[50]  C. Bouchard,et al.  A common polymorphism in the human insulin-like growth factor binding protein 3 gene. , 2000, Molecular and cellular probes.

[51]  R. Kaaks,et al.  Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review , 2000, Prostate Cancer and Prostatic Diseases.

[52]  H. Harpending,et al.  Genetic perspectives on human origins and differentiation. , 2000, Annual review of genomics and human genetics.

[53]  M. Pike,et al.  Cytochrome P450c17α Gene (CYP17) Polymorphism Predicts Use of Hormone Replacement Therapy , 1999 .

[54]  M. Urbanek,et al.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[56]  W. Willett,et al.  The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. , 1999, Cancer research.

[57]  S. Cummings,et al.  Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer , 1999, Annals of Internal Medicine.

[58]  M. Thorén,et al.  Determinants of circulating insulin-like growth factor-I. , 1999, Journal of endocrinological investigation.

[59]  P. Paccotti,et al.  Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features , 1999, Journal of endocrinological investigation.

[60]  J. Manson,et al.  Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.

[61]  C. Mantzoros,et al.  Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. , 1998, Epidemiology.

[62]  Y. Patel,et al.  Polymorphism in the 5' flanking region of the human somatostatin receptor subtype 5. , 1998, Gene.

[63]  C. Mantzoros,et al.  Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. , 1998, Journal of the National Cancer Institute.

[64]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[65]  J. Imperato-McGinley,et al.  Natural potent androgens: lessons from human genetic models. , 1998, Bailliere's clinical endocrinology and metabolism.

[66]  M. Urbanek,et al.  Phenotype and genotype in polycystic ovary syndrome. , 1998, Recent progress in hormone research.

[67]  A. Conney,et al.  Functional role of estrogen metabolism in target cells: review and perspectives. , 1998, Carcinogenesis.

[68]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[69]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[70]  H. Keizer,et al.  Responses of catecholestrogen metabolism to acute graded exercise in normal menstruating women before and after training. , 1997, The Journal of clinical endocrinology and metabolism.

[71]  U. de Faire,et al.  Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: results from middle-aged and elderly monozygotic twins. , 1997, The Journal of endocrinology.

[72]  G. Coetzee,et al.  A polymorphism in the CYP17 gene increases the risk of breast cancer. , 1997, Cancer research.

[73]  S. Franks,et al.  Polycystic ovary syndrome. , 1995, Archives of disease in childhood.

[74]  M. Dowsett,et al.  A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. , 1997, British Journal of Cancer.

[75]  C. Mantzoros,et al.  Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. , 1997, British Journal of Cancer.

[76]  J. Kaprio,et al.  Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. , 1996, The Journal of clinical investigation.

[77]  Julian Peto,et al.  Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.

[78]  M. Bosland,et al.  Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. , 1996, Progress in clinical and biological research.

[79]  D. Ehrmann,et al.  Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. , 1995, Endocrine reviews.

[80]  R. Klein,et al.  Association of dietary and life-style factors with sex hormones in postmenopausal women. , 1995, Epidemiology.

[81]  G. Secreto,et al.  Abnormal production of androgens in women with breast cancer. , 1994, Anticancer research.

[82]  V. Randall.  9 Role of 5α-reductase in health and disease , 1994 .

[83]  J. Cara.  Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. , 1994, Hormone research.

[84]  J. Bonneterre,et al.  Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. , 1993, European journal of cancer.

[85]  C. Martucci,et al.  P450 enzymes of estrogen metabolism. , 1993, Pharmacology & therapeutics.

[86]  L. Bernstein,et al.  Endogenous hormones and breast cancer risk. , 1993, Epidemiologic reviews.

[87]  Wen-Hsiung Li,et al.  Low nucleotide diversity in man. , 1991, Genetics.

[88]  R. Santen,et al.  Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. , 1991, The Journal of clinical endocrinology and metabolism.

[89]  K. Hatch,et al.  Endometrial cancer, obesity, and body fat distribution. , 1991, Cancer research.

[90]  H. Bradlow,et al.  Increased urinary catechol estrogen excretion in female smokers , 1988, Steroids.

[91]  M. Pike,et al.  The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. , 1988, European journal of cancer & clinical oncology.

[92]  P. Siiteri.  Adipose tissue as a source of hormones. , 1987, The American journal of clinical nutrition.

[93]  L. Terracio,et al.  Direct stimulatory effects of insulin-like growth factor-I on Leydig cell steroidogenesis in primary culture. , 1986, Biochemical and biophysical research communications.

[94]  P. Ball,et al.  Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. , 1980, Acta endocrinologica. Supplementum.